The diagnostic role of autoantibodies in the prediction of organ-specific autoimmune diseases

Clinical Chemistry and Laboratory Medicine

Volumn 46, Issue 5, 2008, Pages 577-587

  Tozzoli, Renato ^a  

^a Ospedale Civile   (Italy)

Author keywords

Autoantibodies; Multiplex immunoassays; Organ specific autoimmune diseases; Predictive role; Screening

Indexed keywords

AUTOANTIBODY; BETA 1 ADRENERGIC RECEPTOR ANTIBODY; CHITOBIOSIDE ANTIBODY; DESMOGLEIN 3 ANTIBODY; ENDOMYSIUM ANTIBODY; GLUTAMATE DECARBOXYLASE ANTIBODY; HEART ANTIBODY; INSULIN ANTIBODY; LAMINARIBIOSIDE ANTIBODY; MANNOBIOSIDE ANTIBODY; MITOCHONDRION ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; OUTER MEMBRANE PORIN C ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; PYRUVATE DEHYDROGENASE ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROTROPIN RECEPTOR ANTIBODY;

ADDISON DISEASE; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; AUTOIMMUNE DISEASE; CELIAC DISEASE; CONGESTIVE CARDIOMYOPATHY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; GRAVES DISEASE; HASHIMOTO DISEASE; HIGH RISK POPULATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; PEMPHIGUS VULGARIS; PREGNANCY DIABETES MELLITUS; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROTEOMICS; REVIEW; ULCERATIVE COLITIS;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; HUMANS; PREDICTIVE VALUE OF TESTS;

EID: 44349164625     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2008.138     Document Type: Review

References (107)

1. Eaton WW, Rose NR, Kalaydjian A, Pedersen MG, Mortensen PB. Epidemiology of autoimmune diseases in Denmark. J Autoimmun 2007;29:1-9.
2. Cooper GS, Strohla BC. The epidemiology of autoimmune diseases. Autoimmun Rev 2003;2:119-25.
3. Coco G, Dal Pra C, Presotto F, Albergoni MP, Canova C, Pedini B, et al. Estimated risk for developing autoimmune Addison's disease in patients with adrenal cortex antibodies. J Clin Endocrinol Metab 2006;91:1637-45.
4. Vanderpump MP, Turnbridge WM, French JM, Appleton D, Bates D, Clark F, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickam Survey. Clin Endocrinol 1995;43:55-68.
5. Bizzaro N, Tozzoli R, Shoenfeld Y. Are we at a stage to predict autoimmune rheumatic diseases? Arthritis Rheum 2007;56:1736-44.
6. Notkins AL. New predictors of disease. Molecules called predictive autoantibodies appear in the blood years before people show symptoms of various disorders. Test that detected these molecules could warn of the need to take preventive action. Sci Am 2007;296:72-9.
7. Bizzaro N. Autoantibodies as predictors of disease: The clinical and experimental evidence. Autoimmun Rev 2007;56:1765-75.
8. Scofield RH. Autoantibodies as predictors of disease. Lancet 2004;363:1544-6.
9. Barker JM, Barriga KJ, Yu L, Miao D, Erlich HA, Norris JM, et al. Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study In The Young (DAISY). J Clin Endocrinol Metab 2004;89:3896-902.
10. Kisand KE, Metsküla K, Kisand KV, Kivik T, Gershwin ME, Uibo R. The follow-up of asymptomatic persons with antibodies to pyruvate dehydrogenase in adult population samples. J Gastroenterol 2001;36:248-54.
11. Israeli E, Grotto I, Gilburd B, Balicer RD, Goldin E, Wiik A, et al. Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel diseases. Gut 2005;54:1232-6.
12. Hoffenberg EJ, MacKenzie T, Barriga KJ, Eisenbarth GS, Bao F, Haas JE, et al. A prospective study of the incidence of childhood celiac disease. J Pediatr 2003;143:308-14.
13. Caforio AL, Mahon NG, Baig MK, Tona F, Murphy RT, Elliott PM, et al. Prospective familial assessment in dilated cardiomyopathy: cardiac autoantibodies predict disease development in asymptomatic relatives. Circulation 2007;115:76-83.
14. Premawardhana LD, Parkes AB, John R, Harris B, Lazarus JH. Thyroid peroxidase antibodies in early pregnancy: utility for prediction of postpartum thyroid dysfunction and implications for screening. Thyroid 2004;14:610-5.
15. Jarvela IY, Juutinen J, Koskela P, Hartikainen A-L, Kulmala P, Knip M, et al. Gestational diabetes identifies women at risk for permanent type 1 and type 2 diabetes in fertile age. Diabetes Care 2006;29:607-12.
16. Cappelli C, Gandossi E, Castellano M, Pizzocaro C, Agosti B, Delbarba A, et al. Prognostic value of thyrotropin receptor antibodies (TRAb) in Graves' disease: a 120 months prospective study. Endocr J 2007;54:713-20.
17. Muller R, Svoboda S, Wenzel E, Muller H-H, Hertl M. IgG against extracellular ectodomains of desmoglein 3 relates to clinical phenotype of pemphigus vulgaris. Exp Dermatol 2008;17:35-43.
18. Storck S, Boivin V, Horf R, Hein L, Lohse MJ, Angermann CE, et al. Stimulating autoantibodies directed against cardiac b1-adrenergic receptor predict increased mortality in idiopathic cardiomyopathy. Am Heart J 2006;152:697-704.
19. Ferrante M, Henckaerts L, Joossens M, Pierik M, Joossens S, Dotan N, et al. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Gut 2007;56:1394-403.
20. McLachlan SM, Rapoport B. Thyroid peroxidase as an autoantigen. Thyroid 2007;17:939-48.
21. Tozzoli R, Villalta D, Kodermaz G, Bagnasco M, Tonutti E, Bizzaro N. Autoantibody profiling of patients with autoimmune thyroid disease using a new multiplexed immunoassay method. Clin Chem Lab Med 2006;44:837-42.
22. Prummel MF, Wiersinga WM. Thyroid peroxidase antibodies in healthy subjects. Best Pract Res Endocrinol Metab 2005;19:1-15.
23. Hollowell J, Staheling NW, Flanders WD, Hannon VH, Gunter EW, Spencer T, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002;87:489-99.
24. Huber G, Staub JJ, Meier C, Mitrache C, Guglielmetti M, Huber P, et al. Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies. J Clin Endocrinol Metab 2002;87:3221-6.
25. Bonifacio E, Achenbach P. Autoantibody characteristics and combinations in the prediction of type 1 diabetes. In: Conrad K, Chan EK, Fritzler MJ, Sack U, Shoenfeld Y, Wiik A, editors. From etiopathogenesis to the prediction of autoimmune diseases: relevance of autoantibodies. Lengerich: Pabst Science Publishers, 2007:326-37.
26. Hummel M, Bonifacio E, Schmid S, Walter M, Knopff A, Ziegler A-G. Early appearance of islet autoantibodies predicts childhood type 1 diabetes in offspring of diabetic patients. Ann Intern Med 2004;140:882-6.
27. Kimpimaki T, Kulmala P, Savola K, Kupila A, Korhonen S, Simell T, et al. Natural history of β-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population. J Clin Endocrinol Metab 2002;87:4572-9.
28. Schatz D, Krishner J, Horne G, Riley W, Spillar R, Silverstein J, et al. Islet cells antibodies predict insulin-dependent diabetes in United States school age children as powerfully as in unaffected relatives. J Clin Invest 1994;93:2403-7.
29. Samuelsson U, Sundkvist G, Borg H, Fernlund P, Lundgvisson J. Islet autoantibodies in the prediction of diabetes in school children. Diabetes Res Clin Pract 2001;51:51-7.
30. Kulmala P, Rahko J, Savola K, Vasahalo P, Sjoroos M, Reunanen A, et al. Beta-cell autoimmunity, genetic susceptibility, and progression to diabetes in unaffected children. Diabetes Care 2001;24:171-3.
31. LaGasse JM, Brantley MS, Leech NJ, Rowe RE, Monks S, Palmer JP, et al. Successful prospective prediction of type 1 diabetes in schoolchildren through multiple defined autoantibodies. Diabetes Care 2002;25:505-11.
32. Schlosser M, Strebelow M, Wassmuth R, Arnold ML, Breunig I, Rjasanowski I, et al. The Karlsburg type 1 diabetes risk study of a normal schoolchild population: association of β-cell autoantibodies and human leukocyte antigen-DQB1 alleles in antibody-positive individuals. J Clin Endocrinol Metab 2002;87:2254-61.
33. MacLaren NK, Lan MS, Schatz D, Malone J, Notkins AL, Krischer J. Multiple autoantibodies as predictors of type 1 diabetes in a general population. Diabetologia 2003;46:873-4.
34. Achenbach P, Warncke K, Reiter J, Naserke HE, Williams AJ, Bingley PJ, et al. Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics. Diabetes 2004;53:384-92.
35. Mayr A, Schlosser M, Grober N, Kenk H, Ziegler AG, Bonifacio E, et al. Autoantibody affinity and epitope specificity identify distinct immunization profiles in children at risk for type 1 diabetes. Diabetes 2007;56:1527-33.
36. Sinclair D, Spedding A, Young R. Can the laboratory affect the investigation and diagnosis of primary biliary cirrhosis? J Clin Pathol 2006;59:360-2.
37. Mitchison HC, Bassendine MF, Hendrick A, Bennett MK, Bird G, Watson AJ, et al. Positive antimitochondrial antibodies but normal alkaline phosphatase: is this primary biliary cirrhosis? Hepatology 1986;6:1279-84.
38. Metcalf JV, Mitchison HC, Palmer JM, Jones DE, Bassendine MF, James OF. Natural history of early primary biliary cirrhosis. Lancet 1996;348:1399-402.
39. Prince MI, Chetwynd A, Craig WL, Metcalf JV, James OF. Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort. Gut 2004;53:865-70.
40. Wesierska-Gadek J, Penner A, Battezzati PM, Selmi C, Zuin M, et al. Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis. Hepatology 2006;43:1135-44.
41. Papp M, Norman GL, Altorjay I, Lakatos PL. Utility of serological markers in inflammatory bowel diseases: gadget or magic? World J Gastroenterol 2007;13:2028-36.
42. Dotan I, Fishman S, Dgani Y, Schwartz M, Karban A, Lerner A, et al. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease. Gastroenterology 2006;131:366-78.
43. Landers CJ, Cohavy O, Misra R, Yang H, Lin YC, Braun J, et al. Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens. Gastroenterology 2002;123:689-99.
44. Shanahan F, Duerr RH, Rotter JI, Yang H, Sutherland LR, McElree C, et al. Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneity. Gastroenterology 1992;102:456-61.
45. Seibold F, Slametscha D, Gregor M, Weber P. Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1994;107:532-6.
46. Sendid B, Quinton JF, Charrier G, Goulet O, Cortot A, Grandbastien B, et al. Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease. M J Gastroenterol 1998;93:1306-10.
47. Seibold F, Stich O, Hufnagl R, Kamil S, Scheurlen M. Anti-Saccharomyces cerevisiae antibodies in inflammatory bowel disease: a family study. Scand J Gastroenterol 2001;36:196-201.
48. Maki M, Mustalahti K, Kokkonen J, Kulmala P, Haapalahti M, Karttunen T, et al. Prevalence of celiac disease among children in Finland. N Engl J Med 2003;348:2517-24.
49. Fu M. Autoimmunity and idiopathic dilated cardiomyopathy: where we are? In: Conrad K, Chan EK, Fritzler MJ, Sack U, Shoenfeld Y, Wiik A, editors. From etiopatogenesis to the prediction of autoimmune diseases: relevance of autoantibodies. Lengerich: Pabst Science Publishers, 2007:216-21.
50. Caforio AL, Grazzini M, Mann JM, Keeling PJ, Bottazzo GF, McKenna WJ, et al. Identification of alpha- and betacardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation 1992;85:1734-42.
51. Magnusson Y, Wallukat G, Waagstein F, Hjalmarson A, Hoebeke J. Autoimmunity in idiopathic dilated cardiomyopathy and their symptomatic relatives. Characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect. Circulation 1994;89:2760-7.
52. Fu ML. Anti-M2 muscarinic receptor autoantibodies and idiopathic dilated cardiomyopathy. Int J Cardiol 1996;54:127-35.
53. 1-adrenergic receptor directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest 2004;113:1419-29.
54. Chen J, Larsson L, Haugen E, Fedorkova O, Angwald E, Waagstein F, et al. Effects of autoantibodies removed by immunoadsorption from patients with dilated cardiomyopathy on neonatal rat cardiomyocytes. Eur J Heart Fail 2006;8:460-7.
55. 1-adrenergic receptor induce progressive development of cardiomyopathy. J Mol Cell Cardiol 2007;42:1001-7.
56. Poppe K, Glinoer D. Thyroid autoimmunity and hypothyroidism before and during pregnancy. Hum Reprod Update 2003;9:149-61.
57. Kokandi AA, Parkes AB. Premawardhana LD, John R, Lazarus JH. Association of postpartum thyroid dysfunction with antepartum hormonal and immunological changes. J Clin Endocrinol Metab 2003;88:1126-32.
58. Nicholson WK, Robinson KA, Smallridge RC, Ladenson PW, Powe NR. Prevalence of postpartum thyroid dysfunction: a quantitative review. Thyroid 2006;16:573-82.
59. Kuijpens JL, De Haan-Meulman M, Vader HL, Pop VJ, Wirsinga WM, Drexhage HA. Cell-mediated immunity and postpartum thyroid dysfunction: a possibility for the prediction of disease. J Clin Endocrinol Metab 1998;83:1959-66.
60. Kent GN, Stuckey BG, Allen JR, Lambert T, Gee V. Postpartum thyroid dysfunction: clinical assessment and relationship to psychiatric affective morbidity. Clin Endocrinol (Oxf) 1999;51:429-38.
61. Nohr SB, Jorgensen A, Pedersen KM, Laurberg P. Postpartum thyroid dysfunction in pregnant thyroid peroxidase antibody-positive women living in an area with mild to moderate iodine deficiency: is iodine supplementation safe? J Clin Endocrinol Metab 2000;85:3191-8.
62. Barca MF, Knobel M, Tomimori E, Cardia MS, Medeiros-Neto G. Prevalence and characteristics of postpartum thyroid dysfunction in San Paulo, Brazil. Clin Endocrinol (Oxf) 2000;53:21-31.
63. Kita M, Goulis DG, Avramides A. Postpartum thyroiditis in a Mediterranean population: a prospective study of a large cohort of thyroid antibody positive women at the time of delivery. J Endocrinol Invest 2002;25:513-9.
64. Da Costa SM, Netto LS, Coeli CM, Buescu A, Vaisman M. Value of combined clinical information and thyroid peroxidase antibodies in pregnancy for the prediction of postpartum thyroid dysfunction. Am J Reprod Immunol 2007;58:344-9.
65. Lazarus JH, Premawardhana LD. Screening for thyroid disease in pregnancy. J Clin Pathol 2005;58:449-52.
66. Negro R, Greco G, Mangieri T, Pezzarossa A, Bazzi D, Hassan H. The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase antibodies. J Clin Endocrinol Metab 2007;92:1263-8.
67. American Diabetes Association. Diagnosis and classification of diabetes mellitus (Position Statement). Diabetes Care 2005;28(Suppl 1):S37-42.
68. Fuchtenbush M, Ferber K, Standl E, Ziegeler AG. Prediction of type 1 diabetes postpartum in patients with gestational diabetes mellitus by combined islet autoantibody screening. Diabetes 1997;46:1459-67.
69. Ferber KM, Keller E, Albert ED, Ziegler A-G. Predictive value of human leukocyte antigen class II typing for the development of islet autoantibodies and insulin-dependent diabetes postpartum in women with gestational diabetes. J Clin Endocrinol Metab 1999;84:2342-8.
70. Lobner K, Knopff A, Baumgarten A, Mollenhauer U, Marienfeld S, Garrido-Franco M, et al. Predictors of postpartum diabetes in women with gestational diabetes mellitus. Diabetes 2006;55:792-7.
71. Nilsson C, Ursing D, Torn C, Aberg A, Landin-Olsson M. Presence of GAD antibodies during gestational diabetes mellitus predicts type 1 diabetes. Diabetes Care 2007;30:1968-71.
72. Betterle C, Zanette F, Zanchetta R, Pedini B, Trevisan A, Mantero F, et al. Complement-fixing adrenal autoantibodies as a marker for predicting onset of idiopathic Addison's disease. Lancet 1983;1:1238-40.
73. Ahonen P, Miettinen A, Perheentupa J. Adrenal and steroidal cell antibodies in patients with autoimmune polyglandular disease type 1 and risk of adrenocortical and ovarian failure. J Clin Endocrinol Metab 1987;54:494-500.
74. Betterle C, Scalici C, Presotto F, Pedini B, Moro L, Rigon F, et al. The natural history of adrenal function in autoimmune patients with adrenal autoantibodies. J Endocrinol 1988;117:467-75.
75. De Bellis A, Bizzarro A, Rossi R, Amoresano Paglionico V, Crisciulo T, Lombardi G, et al. Remission of subclinical adrenocortical failure in subjects with adrenal autoantibodies. J Clin Endocrinol Metab 1993;76:1002-7.
76. Peterson P, Salmi H, Hyoly H, Miettinen A, Ilonen J, Reijonen H, et al. Steroid 21-hydroxylase autoantibodies in insulin-dependent diabetes mellitus. Clin Immunol Immunopathol 1997;82:37-42.
77. Betterle C, Volpato M, Rees Smith B, Furmaniak J, Chen S, Greggio NA, et al. Adrenal cortex and steroid 21-hydroxylase autoantibodies in adult patients with organ-specific autoimmune diseases: markers of low progression to clinical Addison's disease. J Clin Endocrinol Metab 1997;82:932-8.
78. Betterle C, Volpato M, Rees Smith B, Furmaniak J, Chen S, Zanchetta R, et al. Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases: markers of high progression to clinical Addison's disease. J Clin Endocrinol Metab 1997;82:939-42.
79. Laureti S, De Bellis A, Muccitelli VI, Calcinaro F, Bizzarro A, Rossi R, et al. Levels of adrenocortical autoantibodies correlate with the degree of adrenal dysfunction in subjects with preclinical Addison's disease. J Clin Endocrinol Metab 1998;83:3507-11
80. Yu L, Brewer KW, Gates S, Wu A, Wang T, Babu SR, et al. DRB1*04 and DQ alleles expression of 21-hydroxylase autoantibodies and risk of progression to Addison's disease. J Clin Endocrinol Metab 1999;84:328-35.
81. Barker JM, Ide A, Hostetler C, Yu L, Miao D, Fain PR, et al. Endocrine and immunogenetic testing in individuals with type 1 diabetes and 21-hydroxylase autoantibodies. Addison's disease in a high risk population. J Clin Endocrinol Metab 2005;90:28-34.
82. Rees Smith B, Sanders J, Furmaniak J. TSH receptor antibodies. Thyroid 2007;17:923-38.
83. Costagliola S, Morgenthaler NG, Hoermann R, Badenhoop K, Struck J, Freitag D, et al. Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Greaves' disease. J Clin Endocrinol Metab 1999;84:90-7.
84. Rees Smith B, Bolton J, Young S, Collyer A, Weeden A, Bradbury J, et al. A new assay for thyrotropin receptor antibodies. Thyroid 2004;14:830-5.
85. Maugendre D, Massart C. Clinical value of a new RSH binding inhibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease: comparison with thyroid stimulating antibody bioassay. Clin Endocrinol (Oxf) 2001;54:89-96.
86. Zimmermann-Belsing T, Nygaard B, Rasmussen AK, Feldt-Rasmussen U. Use of 2nd generation TRAK human assay did not improve prediction of relapse after thyroid medical therapy of Graves' disease. Eur J Endocrinol 2002;146:173-7.
87. Schott M, Morgenthaler NG, Fritzen R, Feldkamp J, Willenberg HS, Scherbaum WA, et al. Levels of autoantibodies against human TSH receptor predict relapse of hyperthyroidism in Graves' disease. Horm Metab Res 2004;36:92-6.
88. Izumi Y, Takeoka K, Amino M. Usefulness of the 2nd generation assay for anti-TSH receptor antibodies to differentiated relapse of Graves' thyrotoxicosis from development of painless thyroiditis after antithyroid drug treatment for Graves' disease. Endocr J 2005;52:493-7.
89. Quadbeck B, Hoermann R, Roggenbruck U, Hahn S, Mann K, Janssen OE, et al. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease. Thyroid 2005;15:1047-54.
90. Carella C, Mazziotti G, Sorvillo F, Piscopo M, Cioffi M, Pilla P, et al. Serum thyrotropin receptor antibodies concentrations in patients with Graves' disease before, at the end of methimazole treatment, and after drug withdrawal: evidence that the activity of thyrotropin receptor antibody and/or thyroid response modify during the observation period. Thyroid 2006;16:295-302.
91. Okamoto Y, Tanigawa S-I, Ishikawa K, Hamada N. TSH receptor antibody measurements and prediction of remission in Graves' disease patients treated with minimum maintenance doses of antithyroid drugs. Endocr J 2006;53:467-72.
92. Harman KE, Seed PT, Gratian MJ, Bhogal BS, Challacombe SJ, Black MM. The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels. Br J Dermatol 2001;144:755-80.
93. Wallukat G. Functional autoantibodies against G-protein coupled receptors. In: Conrad K, Chan EK, Fritzler MJ, Sack U, Shoenfeld Y, Wiik A, editors. From etiopatogenesis to the prediction of autoimmune diseases: relevance of autoantibodies. Lengerich: Pabst Science Publishers, 2007:222-32.
94. Knebel F, Bohm M, Staudt A, Borges AC, Tepper M, Jochmann N, et al. Reduction of morbidity by immunoadsorption therapy in patients with dilated cardiomyopathy. Int J Cardiol 2004;97:517-20.
95. Tozzoli R. Recent advances in diagnostic technologies and their impact in autoimmune disease. Autoimmun Rev 2007;6:334-40.
96. Robinson WH, Steinman L, Utz PJ. Proteomics technology for the study of autoimmune disease. Arthritis Rheum 2002;46:885-93.
97. Tozzoli R, Bizzaro N. Novel diagnostic methods for autoantibody detection. In: Shoenfeld Y, Gershwin ME, Meroni PL, editors. Autoantibodies. Amsterdam: Elsevier Science BV, 2006:77-82.
98. Fritzler MJ. Advances and applications of multiplexed diagnostic technologies in autoimmune diseases. Lupus 2006;15:422-7.
99. Gonzalez-Buitrago JM. Multiplexed testing in the autoimmunity laboratory. Clin Chem Lab Med 2006;44:1169-74.
100. Yiannaki EE, Zintzaras E, Analatos A, Theodoricou C, Dalekos GN, Germenis AE. Evaluation of a microsphere-based flow cytometric assay for diagnosis of celiac disease. J Immunol Immunochem 2004;25:345-7.
101. Gonzalez C, Garcia-Berrocal B, Talavan T, Casas ML, Navajo JA, Gonzalez-Buitrago JM. Clinical evaluation of a microsphere bead-based flow cytometry assay for the simultaneous determination of anti-thyroid peroxidase and anti-thyroglobulin antibodies. Clin Biochem 2005;38:966-72.
102. Tozzoli R, Kodermaz G, Bizzaro N, Bagnasco M, Villalta D, Tonutti E. Autoantibody profiling of AITD patients using a new multiplexed immunoassay system. Clin Chem Lab Med 2006;44:837-42.
103. Lochman I, Martis P, Burlingame RW, Lochmanova A. Multiplex assays to diagnosis celiac disease. Ann NY Acad Sci 2007;1109:330-7.
104. Shepshelovich D, Shoenfeld Y. Prediction and prevention of autoimmune diseases: additional aspects of the mosaic of autoimmunity. Lupus 2006;15:183-90.
105. Harel M, Shoenfeld Y. Predicting and preventing autoimmunity, myth or reality? Ann N Y Acad Sci 2006;1069:322-45.
106. Tozzoli R, Bizzaro N, Tonutti E, Pradella M, Manoni F, Villalta D, et al. Immunoassay of anti-thyroid autoantibodies: high analytical variability in second generation methods. Clin Chem Lab Med 2002;40:568-73.
107. Achenbach P, Schlosser M, Williams AJ, Yu L, Mueller PW, Bingley PJ, et al. Combined testing of antibody titre and affinity improves insulin autoantibody measurement: Diabetes Antibody Standardization Program. Clin Immunol 2007;122:85-90.